Research & Article

The clinical course and its correlated immune status in COVID-19 pneumonia

ชื่อเรื่อง : The clinical course and its correlated immune status in COVID-19 pneumonia

ชื่อผู้แต่ง : Ruyuan He, Zilong Lu, Lin Zhang, Tao Fan, Rui Xiong, Xiaokang Shen, Haojie Feng, Heng Meng, Weichen Lin, Wenyang Jiang, Qing Geng

สำนักพิมพ์ : ELSEVIER

เนื้อหาโดยย่อ : Abstract: Objectives
To explore the clinical course and its dynamic features of immune status in COVID-19 patients and find predictors correlated with severity and prognosis of COVID-19.
Methods
The electronic medical records of 204 patients with COVID-19 pneumonia confirmed by nucleic acid testing were retrospectively collected and analyzed.
Results
All Patients were divided into severe (69) and non-severe group (135). Lymphocyte subsets count, including CD3 + T cell, CD4 + T cell, CD8 + T cell, B cell (CD19+) and NK cell (CD16 + 56+), were significantly lower in severe group (P<0.001). The dynamic levels of T lymphocytes in severe group were significantly lower from disease onset, but in the improved subgroup the value of T lymphocyte began to increase after about 15-day treatment and finally returned to the normal level. The cut-off value of the counts of CD3+ (576), CD4+ (391) and CD8+ (214) T cell were calculated and indicated significantly high sensitivity and specificity for severity of COVID-19.
Conclusion
Our results shown that the decrease of CD3+, CD4+ and CD8 + T lymphocyte correlated with the course of patients with COVID-19 pneumonia, especially in severe cases. The level of T lymphocyte could be used as an indicator for prediction of severity and prognosis of patients with COVID-19 pneumonia. The application of glucocorticoid should be cautious in severe cases

Link : Full Text